France - français - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

merck sante - tégafur - gélule - 100 mg - composition pour une gélule > tégafur : 100 mg > uracile : 224 mg - classification agents antinéoplasiques, antimetabolites, analogues des pyrimidines.

Union européenne - français - EMA (European Medicines Agency)

nordic group b.v. - tegafur, gimeracil, l'otéracil - néoplasmes stomacaux - agents antinéoplasiques - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.